background
costeffect
intervent
need
control
transmiss
viral
respiratori
tract
infect
rti
mass
gather
facemask
promis
prevent
measur
howev
previou
studi
efficaci
facemask
inconclus
studi
propos
largescal
http
dx
clusterrandomis
control
trial
test
efficaci
facemask
prevent
respiratori
viral
infect
among
hajj
pilgrim
middl
east
respiratori
syndrom
coronaviru
viral
respiratori
tract
infect
facemask
trial
hajj
pilgrimag
saudi
arabia
present
protocol
illustr
feasibl
promot
collabor
research
group
addit
relev
studi
methodsdesign
clusterrandomis
control
trial
conduct
test
efficaci
standard
facemask
prevent
symptomat
proven
viral
rti
among
pilgrim
hajj
season
mina
mecca
saudi
arabia
trial
compar
use
versu
among
pilgrim
sever
hajj
season
clusterrandomis
done
accommod
tent
ratio
intervent
tent
free
facemask
provid
worn
consist
day
data
flulik
symptom
mask
use
record
diari
nasal
sampl
collect
symptomat
recruit
test
nucleic
acid
respiratori
virus
data
obtain
questionnair
diari
laboratori
test
analys
examin
whether
mask
use
significantli
reduc
frequenc
laboratoryconfirm
respiratori
viral
infect
syndrom
rti
primari
outcom
conclus
trial
provid
valuabl
evid
efficaci
standard
facemask
use
prevent
viral
respiratori
tract
infect
mass
gather
studi
regist
australian
new
zealand
clinic
trial
registri
anzctr
actrn
http
wwwanzctrorgau
viral
respiratori
tract
infect
rti
includ
influenza
major
burden
public
health
interpandem
year
estim
billion
case
influenza
worldwid
million
case
sever
ill
death
fear
global
spread
seriou
respiratori
diseas
persist
light
past
pandem
sever
acut
respiratori
syndrom
sar
influenza
viru
recent
emerg
middl
east
respiratori
syndrom
coronaviru
merscov
everincreas
intern
travel
intensifi
risk
spread
emerg
novel
virus
intensifi
concern
mass
gather
hajj
pilgrimag
pose
particular
risk
transmiss
respiratori
virus
health
author
requir
costeffect
measur
prevent
limit
global
transmiss
respiratori
diseas
facemask
repres
simpl
cheap
supplement
use
handwash
antivir
vaccin
control
viral
rti
result
previou
studi
examin
effect
facemask
either
conflict
inconclus
randomis
control
trial
rct
household
set
found
adher
facemask
use
decreas
risk
influenzalik
ill
ili
metaanalysi
data
trial
show
wear
facemask
protect
ili
show
facemask
protect
laboratoryconfirm
influenza
perhap
due
limit
studi
fig
interestingli
one
nest
casecontrol
studi
show
intermitt
facemask
use
associ
significantli
greater
risk
infect
among
healthcar
worker
hajj
suggest
perhap
infecti
materi
settl
facemask
becom
sourc
direct
hand
transmiss
respiratori
tract
standard
facemask
may
prevent
acquisit
infect
droplet
andor
aerosol
spread
convers
ii
transmiss
infect
subject
major
limit
previou
studi
small
sampl
size
result
lack
studi
strength
detect
import
albeit
moder
eg
protect
effect
facemask
laboratoryconfirm
influenza
infect
largest
studi
undertaken
date
clusterrandomis
trial
household
recruit
find
addit
benefit
combin
facemask
hand
hygien
health
educ
regard
prevent
measur
overal
rate
laboratoryconfirm
viral
infect
although
benefit
secondari
transmiss
rti
laboratoryconfirm
influenza
author
point
concern
underpow
studi
poor
complianc
mask
use
bin
reza
et
al
recommend
suffici
power
may
achiev
larger
trial
multicentr
run
sever
year
author
studi
contend
addit
take
import
step
improv
complianc
mask
use
also
critic
induc
form
herd
immun
widespread
mask
use
consider
logist
cost
issu
consid
design
conduct
trial
public
health
benefit
posit
result
could
substanti
conduct
trial
hajj
pilgrimag
approxim
million
peopl
gather
annual
corner
world
stay
least
day
tent
mina
valley
offer
excel
opportun
conduct
research
semiclos
set
studi
aim
evalu
efficaci
facemask
prevent
laboratoryconfirm
respiratori
viral
infect
syndrom
rti
concurr
transmiss
pattern
influenza
hajj
investig
studi
genet
related
circul
strain
use
deep
genom
sequenc
addit
uptak
influenza
determin
effect
hajj
evalu
use
testneg
casecontrol
design
evalu
efficaci
facemask
laboratoryconfirm
respiratori
viral
infect
includ
influenza
mer
cov
respiratori
virus
hajj
investig
transmiss
pattern
influenza
viru
hajj
studi
genet
related
circul
influenza
virus
use
deep
genom
sequenc
determin
selfreport
influenza
vaccin
uptak
evalu
effect
hajj
use
testneg
casecontrol
design
largescal
clusterrandomis
control
trial
plan
compar
use
versu
may
choos
use
facemask
among
pilgrim
three
consecut
hajj
pilgrimag
clusterrandomis
arm
ratio
done
accord
accommod
tent
computergener
random
number
gener
offsit
research
coordin
take
part
recruit
assess
particip
randomis
stratifi
gender
countri
resid
ensur
balanc
proportion
recruit
key
step
studi
shown
fig
hajj
pilgrim
recruit
saudi
arabia
qatar
australia
wherea
particip
also
recruit
least
follow
countri
indonesia
malaysia
turkey
morocco
india
pakistan
bangladesh
tabl
commenc
hajj
tour
group
provid
detail
inform
studi
countri
encourag
particip
hajj
train
studi
staff
approach
tour
group
leader
tent
recruit
first
day
stay
mina
research
team
member
explain
studi
detail
assembl
pilgrim
invit
particip
studi
agre
inform
consent
obtain
baselin
questionnair
complet
includ
data
demograph
clinic
inform
recent
respiratori
symptom
appendix
particip
caregiv
blind
randomis
inform
alloc
supervis
facemask
wear
standard
care
howev
laboratori
staff
statist
analyst
blind
alloc
fig
key
step
studi
hajj
key
step
remain
except
recruit
date
advanc
day
age
year
particip
anoth
clinic
trial
investig
medic
intervent
may
interfer
studi
outcom
measur
like
laboratoryconfirm
viral
rti
known
contraind
mask
use
eg
allergi
standard
surgic
mask
materi
refusalor
inabl
sign
consent
form
tent
assign
mask
use
facemask
provid
particip
worn
continu
possibl
replac
everi
six
hour
sooner
wet
use
day
mina
includ
arafat
prefer
addit
day
leav
mina
standard
facemask
studi
tm
standard
tieon
surgic
mask
cat
mask
may
briefli
remov
eat
pray
wash
brush
teeth
pilgrim
experi
discomfort
oral
written
inform
instruct
correct
mask
wear
dispos
provid
mask
group
appendix
b
studi
staff
practic
demonstr
correct
method
wear
mask
also
help
pilgrim
put
mask
first
time
small
plastic
bag
provid
mask
dispos
subject
instruct
discard
plastic
bag
contain
use
mask
local
wast
bin
subset
use
mask
save
test
multiplex
viral
pcr
research
team
member
visit
tent
morn
even
distribut
addit
facemask
pilgrim
requir
extra
document
develop
report
rti
symptom
studi
staff
inter
alia
record
tent
number
number
peopl
recruit
total
number
peopl
tent
pilgrim
provid
hajj
health
diari
appendix
c
day
mina
correspond
octob
second
diari
hitherto
name
posthajj
health
diari
appendix
next
day
leav
mina
diari
uniqu
identifi
barcod
link
studi
particip
number
diari
appendic
c
contain
question
demograph
medic
condit
influenza
vaccin
histori
particip
whether
intervent
control
tent
provid
inform
presenc
absenc
respiratori
symptom
fever
diari
everi
day
whenev
conveni
morn
even
pilgrim
also
record
diari
amount
time
worn
mask
number
mask
use
day
whether
wear
one
sleep
overnight
addit
english
studi
document
diari
questionnair
avail
variou
languag
includ
arab
bahasa
indonesia
bahasa
malaysia
multilingu
research
team
member
remain
avail
help
particip
speak
english
mask
provid
anyon
control
tent
although
pilgrim
may
use
suppli
mask
hajj
health
diari
appendix
c
collect
even
fourth
day
time
posthajj
health
diari
appendix
distribut
pilgrim
selfaddress
prepaid
envelop
pilgrim
instruct
post
diari
research
tour
oper
may
collect
behalf
studi
pilgrim
whose
hajj
health
diari
appendix
c
collect
fourth
day
instruct
return
togeth
posthajj
health
diari
appendix
envelop
group
studi
staff
activ
search
pilgrim
suffer
rti
defin
subject
measur
fever
least
one
respiratori
symptom
cough
sore
throat
rhinorrhoea
twice
day
nasopharyng
np
swab
throat
swab
np
swab
difficult
obtain
collect
symptomat
pilgrim
train
staff
member
later
molecular
diagnost
test
detect
respiratori
virus
swab
use
copan
flock
nasal
swab
viral
transport
medium
part
routin
care
pilgrim
group
suppli
gener
medic
acetaminophen
ibuprofen
fever
ach
swab
store
within
h
collect
later
ship
molecular
diagnost
test
centr
infecti
diseas
microbiolog
laboratori
servic
cidml
westmead
hospit
nsw
australia
pilgrim
ask
provid
email
address
phone
number
mail
address
wish
receiv
result
laboratori
test
nucleic
acid
test
use
multiplex
revers
transcriptas
polymeras
chain
reaction
rtpcr
influenza
b
merscov
coronavirus
parainfluenza
virus
type
rsv
b
adenovirus
human
metapneumoviru
hmpv
picornavirus
perform
nasal
swab
determin
transmiss
pattern
influenza
virus
among
hajj
pilgrim
complet
genom
sequenc
influenza
virus
obtain
use
nextgener
deep
sequenc
protocol
use
illumina
miseq
sequenc
avail
westmead
hospit
gener
multipl
read
per
host
coverag
per
host
sequenc
data
gener
assembl
align
use
geneiou
http
wwwgeneiouscom
vicuna
packag
downstream
phylogenet
evolutionari
analysi
undertaken
use
geneiou
semin
phyml
beast
packag
data
hand
possibl
investig
whether
studi
particip
infect
prior
hajj
ii
whether
direct
viral
transmiss
among
studi
particip
harbour
close
relat
genet
variant
iii
direct
transmiss
establish
whether
occur
frequent
mask
versu
control
group
respiratori
sampl
store
year
revalid
result
discard
accord
standard
oper
procedur
cidml
particip
follow
eg
telephon
mail
email
countri
resid
collect
posthajj
health
diari
well
hajj
health
diari
collect
earlier
consent
studi
particip
allow
contact
gpsfamili
physician
avail
valid
clinic
detail
includ
vaccin
histori
subsequ
infect
gp
consult
hospit
admiss
data
avail
questionnair
diari
laboratori
test
analys
anonym
examin
whether
mask
use
make
signific
differ
reduc
frequenc
laboratoryconfirm
respiratori
viral
infect
includ
influenza
coronaviru
respiratori
virus
syndrom
rti
primari
endpoint
efficaci
facemask
rti
laboratoryconfirm
virus
respect
analys
intentiontotreat
selfreport
uptak
rate
influenza
vaccin
determin
vaccin
effect
estim
base
caseneg
casecontrol
methodolog
result
genom
sequenc
influenza
viru
assist
us
understand
genet
related
circul
influenza
strain
hajj
transmiss
pattern
influenza
among
pilgrim
assum
moder
intraclust
correl
mean
particip
per
cluster
tent
inflat
sampl
moder
larg
factor
account
cluster
sampl
size
requir
clusterrandomis
control
trial
detect
reduct
laboratoryconfirm
viral
respiratori
infect
power
signific
per
arm
addit
inflat
factor
allow
loss
followup
loss
due
priori
infect
high
penetr
incomplet
outcom
data
result
sampl
size
approxim
particip
per
treatment
make
total
first
primari
outcom
clinicalsyndrom
rti
smaller
sampl
would
suffici
answer
gener
question
name
prevent
symptomat
rti
sampl
size
requir
detect
reduct
preval
rti
power
signific
adjust
cluster
loss
followup
particip
per
treatment
make
total
achiev
full
sampl
size
aim
conduct
studi
three
year
attempt
recruit
proportion
balanc
number
pilgrim
particip
countri
accord
number
pilgrim
attend
hajj
countri
see
tabl
trial
receiv
approv
australian
human
research
ethic
committe
nsw
hrec
ref
joint
institut
review
board
jirb
hamad
medic
corpor
weill
cornel
medic
colleg
qatar
irb
number
studi
coordin
particip
countri
provid
modifi
ethic
committe
submiss
collabor
assist
appli
ethic
approv
relev
committe
particip
provid
written
inform
consent
take
part
includ
studi
particip
told
take
part
studi
would
voluntari
confidenti
particip
assign
studi
identif
id
number
data
collect
store
number
data
store
anonym
use
studi
id
number
hard
copi
questionnair
store
secur
lock
file
cabinet
lock
offic
electron
data
store
passwordprotect
comput
file
member
research
team
access
data
hard
copi
retain
least
year
data
manag
protocol
particip
countri
requir
dispos
accord
standard
data
manag
guidelin
conduct
success
studi
largest
trial
assess
efficaci
standard
facemask
rti
includ
influenza
thu
would
add
evid
compendium
physic
intervent
respons
influenza
pandem
addit
one
largest
studi
conduct
hajj
involv
extens
intern
collabor
addit
studi
address
newli
emerg
merscov
threat
potenti
role
facemask
prevent
also
hope
involv
intern
collabor
studi
burden
nasopharyng
acquisit
antibioticresist
colonis
microb
assess
impact
facemask
use
prevent
infect
howev
mani
challeng
effici
orchestr
trial
need
achiev
studi
object
includ
train
larg
number
studi
research
volunt
n
lead
team
conduct
trial
appropri
data
collect
storag
transport
sampl
optimum
temperatur
addit
complianc
facemask
use
intervent
tent
must
optimis
contamin
may
occur
wherebi
subject
control
tent
may
use
facemask
issu
would
address
analys
data
respect
complianc
facemask
use
addit
intentiontotreat
analysi
studi
staff
visit
intervent
tent
twice
day
encourag
mask
use
advis
peopl
problem
wear
facemask
studi
staff
similarli
visit
control
tent
encourag
recruit
strictli
maintain
record
facemask
use
complet
diari
collect
sampl
symptomat
pilgrim
recent
pilot
studi
show
high
complianc
could
achiev
facemask
usag
recommend
purpos
explain
merscov
threat
may
impact
studi
anoth
way
highlight
signific
trial
investig
respiratori
diseas
hajj
saudi
arabian
ministri
health
recommend
high
risk
mer
infect
eg
chronic
medic
condit
pregnant
age
year
postpon
pilgrimag
perform
hajj
use
facemask
crowd
place
amongst
cough
pilgrim
mean
confound
behaviour
control
care
measur
includ
multipl
regress
analysi
diari
may
return
despit
sincerest
effort
pilgrim
requir
post
second
set
diari
posthajj
health
diari
replypaid
selfaddress
envelop
might
time
optimis
return
diari
studi
coordin
respect
countri
send
phonemail
remind
recruit
tour
oper
assist
diari
collect
data
qualiti
may
optimum
reli
selfreport
symptom
report
rti
symptom
may
dictat
interest
patient
may
report
specif
symptom
physician
get
prescript
antipyreticspain
killer
studi
staff
frequent
monitor
continu
monitor
feasibl
addit
short
followup
durat
trial
mean
possibl
failur
detect
infect
incub
period
respiratori
virus
may
rang
less
day
eg
rhinoviru
influenza
day
adenoviru
merscov
howev
believ
posthajj
health
diari
reduc
shortcom
extent
despit
limit
success
project
provid
valuabl
data
efficaci
simpl
facemask
prevent
viral
respiratori
infect
hajj
pilgrim
believ
data
may
use
mass
gather
olymp
perhap
close
set
hospit
school
airplan
ship
airport
set
also
repres
power
opportun
studi
precis
pattern
viru
transmiss
detail
comparison
circul
viral
strain
hope
outcom
studi
inform
global
health
author
effect
control
respiratori
viral
infect
conduct
sponsor
research
travel
present
confer
consult
work
fund
receiv
direct
research
account
hospit
westmead
dr
iman
ridda
receiv
grant
investigatordriven
research
gsk
consult
merck
author
declar
conflict
interest
relat
work
